NasdaqCM:NATR

Stock Analysis Report

Nature's Sunshine Products

Executive Summary

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.

Risks

  • Nature's Sunshine Products is not covered by any analysts.

Similar Companies

Share Price & News

How has Nature's Sunshine Products's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-2.7%

NasdaqCM:NATR

8.3%

US Personal Products

0.2%

US Market


1 Year Return

7.3%

NasdaqCM:NATR

18.8%

US Personal Products

-0.7%

US Market

NATR underperformed the Personal Products industry which returned 17.3% over the past year.

NATR outperformed the Market in United States of America which returned 0.3% over the past year.


Share holder returns

NATRIndustryMarket
7 Day-2.7%8.3%0.2%
30 Day0.1%2.5%-2.7%
90 Day-8.4%8.7%1.6%
1 Year7.3%7.3%20.6%18.8%1.6%-0.7%
3 Year-30.5%-31.6%39.0%31.8%40.0%30.9%
5 Year-35.2%-45.9%79.6%61.5%53.8%36.8%

Price Volatility Vs. Market

How volatile is Nature's Sunshine Products's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Nature's Sunshine Products undervalued based on future cash flows and its price relative to the stock market?

57.63x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Nature's Sunshine Products's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Nature's Sunshine Products's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Nature's Sunshine Products is overvalued based on earnings compared to the US Personal Products industry average.

Nature's Sunshine Products is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Nature's Sunshine Products, we can't assess if its growth is good value.


Price Based on Value of Assets

Nature's Sunshine Products is good value based on assets compared to the US Personal Products industry average.


Next Steps

Future Growth

How is Nature's Sunshine Products expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.9%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nature's Sunshine Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Nature's Sunshine Products performed over the past 5 years?

-61.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Nature's Sunshine Products's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.

Nature's Sunshine Products has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.

Nature's Sunshine Products has become profitable in the last year making it difficult to compare the US Personal Products industry average.


Return on Equity

Nature's Sunshine Products has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Nature's Sunshine Products used its assets less efficiently than the US Personal Products industry average last year based on Return on Assets.


Return on Capital Employed

Nature's Sunshine Products's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Nature's Sunshine Products's financial position?


Financial Position Analysis

Nature's Sunshine Products is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Nature's Sunshine Products's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Nature's Sunshine Products's level of debt (1.3%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (8.8% vs 1.3% today).

Debt is well covered by operating cash flow (709.9%, greater than 20% of total debt).

Interest payments on debt are well covered by earnings (EBIT is 33.2x coverage).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 66.6x debt.


Next Steps

Dividend

What is Nature's Sunshine Products's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Nature's Sunshine Products's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Nature's Sunshine Products's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Nature's Sunshine Products has not reported any payouts.

Unable to verify if Nature's Sunshine Products's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Nature's Sunshine Products has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Nature's Sunshine Products's salary, the management and board of directors tenure and is there insider trading?

1.7yrs

Average management tenure


CEO

Terrence Moorehead (56yo)

0.8yrs

Tenure

US$2,996,234

Compensation

Mr. Terrence O. Moorehead has been Chief Executive Officer of Nature's Sunshine Products, Inc since October 1, 2018. He serves as President of Nature's Sunshine Products, Inc. He has been a Director at Nat ...


CEO Compensation Analysis

Terrence's remuneration is higher than average for companies of similar size in United States of America.

Insufficient data for Terrence to compare compensation growth.


Management Age and Tenure

1.7yrs

Average Tenure

54.5yo

Average Age

The average tenure for the Nature's Sunshine Products management team is less than 2 years, this suggests a new team.


Board Age and Tenure

4.8yrs

Average Tenure

58yo

Average Age

The tenure for the Nature's Sunshine Products board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$91018 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares100
Max PriceUS$9.10
BuyUS$98,85514 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares10,933
Max PriceUS$9.09
BuyUS$403,51005 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares42,893
Max PriceUS$9.50
BuyUS$1,23503 Jun 19
Wynnefield Capital, Inc.
EntityCompany
Shares130
Max PriceUS$9.54
BuyUS$95,05230 May 19
Wynnefield Capital, Inc.
EntityCompany
Shares10,000
Max PriceUS$9.55
BuyUS$15,38221 May 19
Wynnefield Capital, Inc.
EntityCompany
Shares1,586
Max PriceUS$9.79
SellUS$26,52007 May 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$8.84
SellUS$28,23005 Apr 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$9.41
BuyUS$17,38518 Mar 19
Wynnefield Capital, Inc.
EntityCompany
Shares1,666
Max PriceUS$10.44
BuyUS$44,54513 Mar 19
Wynnefield Capital, Inc.
EntityCompany
Shares4,681
Max PriceUS$9.52
SellUS$23,79007 Mar 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$7.93
SellUS$23,88008 Feb 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$7.96
SellUS$23,16003 Jan 19
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$7.72
BuyUS$22,23513 Dec 18
Wynnefield Capital, Inc.
EntityCompany
Shares2,516
Max PriceUS$8.85
BuyUS$34,19710 Dec 18
Wynnefield Capital, Inc.
EntityCompany
Shares3,902
Max PriceUS$8.80
SellUS$27,03007 Dec 18
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$9.01
SellUS$27,69006 Dec 18
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$9.23
BuyUS$3,19528 Nov 18
Wynnefield Capital, Inc.
EntityCompany
Shares359
Max PriceUS$8.90
BuyUS$23,28614 Nov 18
Wynnefield Capital, Inc.
EntityCompany
Shares2,644
Max PriceUS$8.81
SellUS$26,01004 Oct 18
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$8.67
SellUS$27,00006 Sep 18
Kristine Hughes
EntityIndividual
Role
Chairman Emeritus
Chairperson Emeritus
Shares3,000
Max PriceUS$9.00

Ownership Breakdown


Management Team

  • Joe Baty (62yo)

    CFO & Executive VP of Finance

    • Tenure: 2.8yrs
    • Compensation: US$993.29k
  • Terrence Moorehead (56yo)

    President

    • Tenure: 0.8yrs
    • Compensation: US$3.00m
  • Bryant Yates (46yo)

    Executive VP & President of Europe

    • Tenure: 0.0yrs
    • Compensation: US$463.38k
  • Lynda Hammons (64yo)

    Senior Vice President of Global Quality & Regulatory Affairs

    • Tenure: 0.0yrs
  • Richard Zhang

    Managing Director of China

    • Tenure: 4.8yrs
  • Henry Zhou

    Managing Director of China for Synergy

    • Tenure: 4.8yrs
  • Eddie Silcock

    Executive VP & President of North America

    • Tenure: 0.3yrs
  • Nathan Brower (39yo)

    Executive VP

    • Tenure: 1.7yrs
  • Tracee Comstock (53yo)

    Vice President of Human Resources

    • Tenure: 1.6yrs
  • Trent McCausland

    Executive Director

    • Tenure: 0.0yrs

Board Members

  • Kristine Hughes (80yo)

    Chairperson Emeritus

    • Tenure: 0.6yrs
    • Compensation: US$125.75k
  • Rick Moss (61yo)

    Director

    • Tenure: 1.3yrs
    • Compensation: US$123.61k
  • Mary Springer (55yo)

    Director

    • Tenure: 5.9yrs
    • Compensation: US$130.27k
  • Jeff Watkins (58yo)

    Independent Director

    • Tenure: 10.2yrs
    • Compensation: US$123.25k
  • Rob Straus (49yo)

    Independent Director

    • Tenure: 2.2yrs
    • Compensation: US$117.83k
  • Terrence Moorehead (56yo)

    President

    • Tenure: 0.8yrs
    • Compensation: US$3.00m
  • Bob Mercer (67yo)

    Independent Director

    • Tenure: 9.0yrs
    • Compensation: US$125.75k
  • Sang Geon Kim

    Member of Medical & Scientific Advisory Board

    • Tenure: 4.9yrs
  • Ingrum Bankston

    Member of Medical & Scientific Advisory Board

    • Tenure: 4.8yrs
  • Trent McCausland

    Executive Director

    • Tenure: 0.0yrs

Company Information

Nature's Sunshine Products, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nature's Sunshine Products, Inc.
  • Ticker: NATR
  • Exchange: NasdaqCM
  • Founded: 1972
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$175.072m
  • Shares outstanding: 19.30m
  • Website: https://www.naturessunshine.com

Number of Employees


Location

  • Nature's Sunshine Products, Inc.
  • 2901 West Bluegrass boulevard
  • Suite 100
  • Lehi
  • Utah
  • 84043
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NATRNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJun 1979

Biography

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide. It operates through four segments ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/20 23:48
End of Day Share Price2019/08/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.